Browsing Tag
Xencor
3 posts
Japan approves Minjuvi for relapsed follicular lymphoma: What does this dual-CD immunotherapy mean for the market?
Incyte’s Minjuvi gets Japan approval for relapsed FL. Find out how this dual-CD regimen is reshaping immunotherapy options in a high-need market.
Xencor stock skyrockets 26% overnight after breakthrough in cancer research
Xencor, Inc., a clinical-stage biopharmaceutical company specializing in engineered antibodies for cancer treatment, saw its stock rise by…
Xencor initiates Phase 1 trial of XmAb20717 for advanced solid tumors
Xencor, a prominent biopharmaceutical company based in Monrovia, California, has recently dosed the first patient in a Phase…